Short Interest in International Stem Cell Co. (OTCMKTS:ISCO) Grows By 400.0%

International Stem Cell Co. (OTCMKTS:ISCO) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,500 shares, an increase of 400.0% from the December 31st total of 300 shares. Based on an average daily volume of 22,400 shares, the days-to-cover ratio is currently 0.1 days.

International Stem Cell Stock Up 16.7 %

International Stem Cell stock traded up $0.02 during trading on Tuesday, reaching $0.11. The stock had a trading volume of 2,401 shares, compared to its average volume of 3,108. International Stem Cell has a 52-week low of $0.05 and a 52-week high of $0.20. The business has a 50 day moving average price of $0.10 and a 200 day moving average price of $0.08. The stock has a market cap of $840,000.00, a PE ratio of -1.31 and a beta of 0.21.

About International Stem Cell

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.